Fig. 1From: Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangementsOverall survival in de novo and relapsed/progressed advanced non-small cell lung cancer CI, confidence intervalBack to article page